These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 20598025)

  • 1. Maternal blood and amniotic fluid levels of moxifloxacin, levofloxacin and cefixime.
    Ozyüncü O; Beksac MS; Nemutlu E; Katlan D; Kir S
    J Obstet Gynaecol Res; 2010 Jun; 36(3):484-7. PubMed ID: 20598025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maternal and fetal blood levels of moxifloxacin, levofloxacin, cefepime and cefoperazone.
    Ozyuncu O; Nemutlu E; Katlan D; Kir S; Beksac MS
    Int J Antimicrob Agents; 2010 Aug; 36(2):175-8. PubMed ID: 20418070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of the newer quinolones levofloxacin and moxifloxacin in plasma by high-performance liquid chromatography with fluorescence detection.
    Schulte S; Ackermann T; Bertram N; Sauerbruch T; Paar WD
    J Chromatogr Sci; 2006 Apr; 44(4):205-8. PubMed ID: 16620519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum bactericidal activities of moxifloxacin and levofloxacin against aerobic and anaerobic intra-abdominal pathogens.
    Stein GE; Schooley S; Tyrrell KL; Citron DM; Nicolau DP; Goldstein EJ
    Anaerobe; 2008 Feb; 14(1):8-12. PubMed ID: 17983770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of moxifloxacin and high-dose levofloxacin in severe lower respiratory tract infections.
    Kontou P; Manika K; Chatzika K; Papaioannou M; Sionidou M; Pitsiou G; Kioumis I
    Int J Antimicrob Agents; 2013 Sep; 42(3):262-7. PubMed ID: 23830621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous quantification of linezolid, rifampicin, levofloxacin, and moxifloxacin in human plasma using high-performance liquid chromatography with UV.
    Baietto L; D'Avolio A; De Rosa FG; Garazzino S; Patanella S; Siccardi M; Sciandra M; Di Perri G
    Ther Drug Monit; 2009 Feb; 31(1):104-9. PubMed ID: 19077929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacodynamics of moxifloxacin and levofloxacin simulating human serum and lung concentrations.
    Schubert S; Dalhoff A; Stass H; Ullmann U
    Infection; 2005 Dec; 33 Suppl 2():15-21. PubMed ID: 16518707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacodynamics of moxifloxacin and levofloxacin against Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae and Escherichia coli: simulation of human plasma concentrations after intravenous dosage in an in vitro kinetic model.
    Odenholt I; Cars O
    J Antimicrob Chemother; 2006 Nov; 58(5):960-5. PubMed ID: 16936293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of a levofloxacin HPLC assay in plasma and dialysate for pharmacokinetic studies.
    Siewert S
    J Pharm Biomed Anal; 2006 Jun; 41(4):1360-2. PubMed ID: 16563690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moxifloxacin versus levofloxacin for treatment of acute rhinosinusitis: a retrospective database analysis of treatment duration, outcomes, and charges.
    Keating KN; Friedman HS; Perfetto EM
    Curr Med Res Opin; 2006 Feb; 22(2):327-33. PubMed ID: 16466604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of ofloxacin and moxifloxacin and their penetration in human aqueous and vitreous humor by using high-performance liquid chromatography fluorescence detection.
    Chan KP; Chu KO; Lai WW; Choy KW; Wang CC; Lam DS; Pang CP
    Anal Biochem; 2006 Jun; 353(1):30-6. PubMed ID: 16620758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Penetration of newer quinolones in the empyema fluid.
    Liapakis IE; Kottakis I; Tzatzarakis MN; Tsatsakis AM; Pitiakoudis MS; Ypsilantis P; Light RW; Simopoulos CE; Bouros DE
    Eur Respir J; 2004 Sep; 24(3):466-70. PubMed ID: 15358708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Community-Acquired Pneumonia Recovery in the Elderly (CAPRIE): efficacy and safety of moxifloxacin therapy versus that of levofloxacin therapy.
    Anzueto A; Niederman MS; Pearle J; Restrepo MI; Heyder A; Choudhri SH;
    Clin Infect Dis; 2006 Jan; 42(1):73-81. PubMed ID: 16323095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increasing amniotic fluid magnesium concentrations with stable maternal serum levels: a prospective clinical trial.
    Gortzak-Uzan L; Mezad D; Smolin A; Friger M; Huleihel M; Hallak M
    J Reprod Med; 2005 Nov; 50(11):817-20. PubMed ID: 16419627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of levofloxacin and moxifloxacin use in hospitalized community-acquired pneumonia (CAP) patients in the US: focus on length of stay.
    Schein J; Janagap-Benson C; Grant R; Sikirica V; Doshi D; Olson W
    Curr Med Res Opin; 2008 Mar; 24(3):895-906. PubMed ID: 18419876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High doses of levofloxacin vs moxifloxacin against staphylococcal experimental foreign-body infection: the effect of higher MIC-related pharmacokinetic parameters on efficacy.
    Murillo O; Pachón ME; Euba G; Verdaguer R; Tubau F; Cabellos C; Cabo J; Gudiol F; Ariza J
    J Infect; 2009 Mar; 58(3):220-6. PubMed ID: 19217166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moxifloxacin versus levofloxacin against acute exacerbations of chronic bronchitis: the Latin American Cohort.
    Urueta-Robledo J; Ariza H; Jardim JR; Caballero A; García-Calderón A; Amábile-Cuevas CF; Hernández-Oliva G; Vivar-Orozco R;
    Respir Med; 2006 Sep; 100(9):1504-11. PubMed ID: 16504492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of antibiotic effect and corneal epithelial toxicity of levofloxacin and moxifloxacin in vitro.
    Kim SY; Lim JA; Choi JS; Choi EC; Joo CK
    Cornea; 2007 Jul; 26(6):720-5. PubMed ID: 17592324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Moxifloxacin prophylaxis in neutropenic patients.
    von Baum H; Sigge A; Bommer M; Kern WV; Marre R; Döhner H; Kern P; Reuter S
    J Antimicrob Chemother; 2006 Oct; 58(4):891-4. PubMed ID: 16880172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pharmacodynamic approach to antimicrobial activity in serum and epithelial lining fluid against in vivo-selected Streptococcus pneumoniae mutants and association with clinical failure in pneumonia.
    Alou L; Giménez MJ; Sevillano D; Aguilar L; Cafini F; Echeverría O; Pérez-Trallero E; Prieto J
    J Antimicrob Chemother; 2006 Aug; 58(2):349-58. PubMed ID: 16782744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.